[go: up one dir, main page]

AU2002232394A1 - Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis - Google Patents

Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis

Info

Publication number
AU2002232394A1
AU2002232394A1 AU2002232394A AU3239402A AU2002232394A1 AU 2002232394 A1 AU2002232394 A1 AU 2002232394A1 AU 2002232394 A AU2002232394 A AU 2002232394A AU 3239402 A AU3239402 A AU 3239402A AU 2002232394 A1 AU2002232394 A1 AU 2002232394A1
Authority
AU
Australia
Prior art keywords
ahsg
fetuin
glycoprotein
obesity
inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002232394A
Inventor
Anton Scott Goustin
George Grunberger
Kai-Lin Catherine Jen
Suresh T. Mathews
Pothur R. Srinivas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wayne State University
Original Assignee
Wayne State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wayne State University filed Critical Wayne State University
Publication of AU2002232394A1 publication Critical patent/AU2002232394A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/473—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2002232394A 2000-10-27 2001-10-29 Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis Abandoned AU2002232394A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24344200P 2000-10-27 2000-10-27
US60/243,442 2000-10-27
PCT/US2001/042832 WO2002039923A2 (en) 2000-10-27 2001-10-29 Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis

Publications (1)

Publication Number Publication Date
AU2002232394A1 true AU2002232394A1 (en) 2002-05-27

Family

ID=22918793

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002232394A Abandoned AU2002232394A1 (en) 2000-10-27 2001-10-29 Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis

Country Status (3)

Country Link
US (2) US20040198648A1 (en)
AU (1) AU2002232394A1 (en)
WO (1) WO2002039923A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004027048D1 (en) * 2003-07-16 2010-06-17 Resverlogix Inc COMPOUNDS AND METHODS OF DOWNREGULATING THE EFFECTS OF TGF-BETA
CA2654408C (en) 2006-06-06 2018-05-08 Oleg Iliich Epshtein Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
US8962015B2 (en) 2007-09-28 2015-02-24 Sdg, Inc. Orally bioavailable lipid-based constructs
US8846053B2 (en) * 2008-09-26 2014-09-30 Sdg, Inc. Orally bioavailable lipid-based constructs
US9145453B2 (en) * 2007-09-28 2015-09-29 Sdg, Inc. Orally bioavailable lipid-based constructs
US20100080773A1 (en) 2008-09-26 2010-04-01 Sdg, Inc. Orally Bioavailable Lipid-Based Constructs
US20210137838A1 (en) 2017-03-13 2021-05-13 Sdg, Inc. Lipid-based nanoparticles with enhanced stability
US11077173B2 (en) 2017-03-13 2021-08-03 Sdg, Inc. Lipid-based nanoparticles and methods using same
WO2022164854A2 (en) * 2021-01-27 2022-08-04 Immunis, Inc. Methods of preparation of secretomes, and uses thereof
CN115044682B (en) * 2022-06-14 2024-08-30 兰州大学 Molecular markers related to growth traits of Hu sheep, their detection methods and applications

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8087591A (en) * 1990-06-01 1991-12-31 W. Alton Jones Cell Science Center Mammalian adipogenic factors
US5449757A (en) * 1990-06-01 1995-09-12 W. Alton Jones Cell Science Center Mammalian adipogenic factors
EP0623142A4 (en) * 1992-01-17 1995-07-12 Alton Jones Cell Science Cente Mammalian adipogenic factors.

Also Published As

Publication number Publication date
WO2002039923A3 (en) 2003-04-17
US20040198648A1 (en) 2004-10-07
WO2002039923A2 (en) 2002-05-23
US20080050372A1 (en) 2008-02-28

Similar Documents

Publication Publication Date Title
AU2002232394A1 (en) Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis
AU2003222648A1 (en) Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
IL150260A0 (en) Propionic acid derivatives and their use in the treatment of diabetes and obesity
EP1565189A4 (en) Anti-aging skin care composition and uses thereof
AU2003243551A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
GB9927603D0 (en) Use of a milk protein hydrolysate in the treatment of diabetes
HK1162948A1 (en) Hemiasterlin derivatives and uses thereof in the treatment of cancer (hemiasterlin)
AU2002346504A1 (en) Therapeutic protein and treatments
AU2002356278A1 (en) Improvements in and relating to calf compression devices
AU2002353658A1 (en) Method of treating obesity, overweight, diabetes, or fluctuations in blood insuline or glucose levels
AU2001292658A1 (en) Method for treatment of insulin resistance in obesity and diabetes
AU2003278806A1 (en) Composition and method for moisturizing nasal tissue
AU2003253629A1 (en) Large deletions in human brca1 gene and use thereof
AU2002352361A1 (en) Vibration control system and improvements in or relating to skis
AU2003252261A1 (en) System for measuring chromaticity in visible and invisible regions
AU2003238242A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU2001249310A1 (en) Prevention and/or treatment of diabetes mellitus by pharmacologically inhibitingpancreatic beta-cell o-linked protin glycosylation and/or pancreatic beta-cell p135 o-glycosylation
MXPA03000508A (en) REGULATORS OF PPARdgr;(bgr;) AND THEIR USE IN THE TREATMENT OF OBESITY AND INSULIN RESISTANCE.
AU2003201074A1 (en) Herbal synergistic formulation effective against mosquito-larvae and use thereof in controlling malarial vector
GB0226436D0 (en) Improvements in and relating to catheter control
AU4747100A (en) Device for improving respiration and for eliminating snoring
AU2003293500A1 (en) Lactoferrin in the reduction of pain
GB2346178B (en) Integral pump and control valve
AUPR459501A0 (en) Improvements in engines and components
AU5821800A (en) Method for adjusting or controlling the diet and/or a person's consumption